Home › Funds › Citadel Advisors › VRTX
Citadel Advisors position in VRTX
VERTEX PHARMACEUTICALS INCORPORATED · Health Care
Latest position (Q2 2026)889.63K sh
Reported value held$441.91M
Portfolio Weight0.05%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 1.07M | $194.85M | New |
| Q4 2021 | 824.79K | $181.12M | Reduce |
| Q1 2022 | 779.61K | $203.45M | Reduce |
| Q2 2022 | 710.90K | $200.32M | Reduce |
| Q3 2022 | 557.66K | $161.47M | Reduce |
| Q4 2022 | 592.01K | $170.96M | Add |
| Q1 2023 | 363.01K | $114.37M | Reduce |
| Q2 2023 | 209.91K | $73.87M | Reduce |
| Q3 2023 | 305.74K | $106.32M | Add |
| Q4 2023 | 650.08K | $264.51M | Add |
| Q1 2024 | 377.17K | $157.66M | Reduce |
| Q2 2024 | 352.19K | $165.08M | Reduce |
| Q3 2024 | 353.93K | $164.61M | Hold |
| Q4 2024 | 681.08K | $274.27M | Add |
| Q1 2025 | 386.42K | $187.34M | Reduce |
| Q2 2025 | 472.73K | $210.46M | Add |
| Q3 2025 | 584.90K | $229.07M | Add |
| Q4 2025 | 789.96K | $358.14M | Add |
| Q1 2026 | 631.50K | $281.99M | Reduce |
| Q2 2026 | 889.63K | $441.91M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- BlackRock Inc 24.11M sh · $11.98B · Q2 2026
- Vanguard Group 24.11M sh · $10.93B · Q4 2025
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- Geode Capital Management 6.02M sh · $2.98B · Q2 2026
- Franklin Resources 3.35M sh · $1.66B · Q2 2026
- Wellington Management Group 3.25M sh · $1.61B · Q2 2026
- Morgan Stanley 3.24M sh · $1.61B · Q2 2026
- Bank of America Corp 3.04M sh · $1.51B · Q2 2026
- Norges Bank Investment Management 2.97M sh · $1.48B · Q2 2026
- Goldman Sachs Group 2.53M sh · $1.26B · Q2 2026